Bayer buys BlueRock Therapeutics, marks stance cell therapy space
Category: #health  By Mateen Dalal  Date: 2019-08-10
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Bayer buys BlueRock Therapeutics, marks stance cell therapy space
  • Versant Ventures’ portfolio company, Bluerock Therapeutics acquired by Bayer AG for approximately USD 1 billion.
  • This acquisition represents Versant’s robust progress in the region of Canada.

California headquartered Versant Ventures reportedly announced the acquisition of its cell therapy company BlueRock Therapeutics by Germany based Bayer AG which was valued at USD 1 billion. This represents an added important transaction by the Versant-formed companies.

As per credible sources, Versant considered the plan and commenced to build BlueRock in 2015 with opinion that stem cells had the potential to yield regenerative therapeutics based considering the fundamental advances achieved in cell differentiation, production and engineering.

Reportedly, the preliminary seed phase covered over a year allowing the required time to secure foundational technology from the recognized universities of Toronto and New York.

Speculation has it that in December 2016, BlueRock originated with USD 225 million in Series A round led by Versant and Bayer. Making use of this financing, the company extended its ranks with a commendable team including over more than 70 scientists at its R&D facility.

As per sources, Bayer has been claimed to acquire the shares in BlueRock for about USD 600 million, with about USD 240 million up front and up to USD 360 million preclinical and early clinical milestone payments.

Brad Bolzon, the Managing Director and chairman at Versant was reportedly quoted stating that the BlueRock acquisition strengthen the firms’ current approach to recognize the promising new discoveries happening in the field of science across the globe.

Jerel Davis, Managing Director, Versant and board director BlueRock was quoted stating that Versant has successfully established a Canadian presence to identify the unexploited sources of innovations in the emerging fields. The firm is looking forward for a global recognition with Bayer’s acquisition of BlueRock.

For the records, 1999 established Versant Ventures is a principal healthcare venture capital firm dedicated to helping excellent entrepreneurs build the next generation of great companies. The firm lays major emphasis on biotechnology companies that are currently discovering and evolving novel therapeutics.

Source credit: https://www.businesswire.com/news/home/20190808005234/en/Versant-Ventures-Announces-Acquisition-Cell-Therapy-Company

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

Lufthansa Group to swap old A340 planes with 10 new long-haul jets

Lufthansa Group to swap old A340 planes with 10 new long-haul jets

By Mateen Dalal

The parent company of German airline Deutsche Lufthansa AG, Lufthansa Group, reportedly said it would purchase a total of 10 long-haul aircraft, including 5 Boeing B787-9s and 5 Airbus A350-900s, to replace aging Airbus A340 planes in an effort to mo...

Facebook, Google sign content deals with Australia’s Seven West Media

Facebook, Google sign content deals with Australia’s Seven West Media

By Mateen Dalal

Seven West Media, an Australian newspaper and television firm, has reportedly signed a content deal with Facebook Inc. and Google LLC in the wake of recent landmark laws that have enabled the industry to obtain new revenue sources and adapt to the in...

Microsoft considered reducing Xbox Store fee to revive console gaming

Microsoft considered reducing Xbox Store fee to revive console gaming

By Mateen Dalal

Multinational tech-giant Microsoft was reportedly looking to lower its Xbox store commission fee to a meager 12% from the previous 30%, as per confidential documents submitted in the Epic Games and Apple case. The document from January also contains...